Skip to main content
Log in

Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

A study was conducted to determine if a two-dose regimen of influenza vaccine would enhance the immunologic response of 41 patients with lymphoma receiving chemotherapy. Hemagglutinin-inhibiting antibody responses to influenza A/H1N1, A/H3N2 and B virus occurred in 32 %, 24 % and 20 % of patients following one dose, and in 49 %, 41 % and 46 % of patients following two doses, respectively. Responses to one or more vaccine components occurred in 42 % of patients after one dose and in 71 % after two doses. Fifty percent of the patients who did not respond after one dose responded after two doses. A two-dose regimen of influenza immunization may significantly enhance the response rate of cancer patients receiving chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Couch RB, Kasel JA, Glezen WP, Cate TR, Six HR, Taber LH, Frank AL, Greenberg SB, Zahradnik JM, Keitel WA: Influenza: its control in persons and populations. Journal of Infectious Diseases 1986, 153: 431–440.

    PubMed  Google Scholar 

  2. Centers for Disease Control: Prevention and control of influenza. I: Vaccines: recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report 1993, 421: 1–14.

    Google Scholar 

  3. Borella L, Webster RG: The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission. Cancer Research 1971, 31: 420–426.

    PubMed  Google Scholar 

  4. Sybesma J, Holtzer JD, Borst-Eilers E, Moes M, Zegers B: Antibody response in Hodgkin's disease and other lymphomas related to HL-A antigens, immunoglobulin levels and therapy. Vox Sanguinis 1973, 25: 254–262.

    PubMed  Google Scholar 

  5. Feery BJ, Sullivan JR, Hurley TH, Evered MG: Immunization with influenza vaccine in patients with haematological malignant disease. Medical Journal of Australia 1977, 1: 292–294.

    PubMed  Google Scholar 

  6. Ortbals DW, Liebhaber H, Presant CA, Van Amburg AL, Lee JY: Influenza immunization of adult patients with malignant diseases. Annals of Internal Medicine 1977, 87: 552–557.

    PubMed  Google Scholar 

  7. Ganz PA, Shanley JD, Cherry JD: Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer 1978, 42: 2244–2247.

    PubMed  Google Scholar 

  8. Stiver GH, Weinerman BH: Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Canadian Medical Association Journal 1978, 119: 733–738.

    PubMed  Google Scholar 

  9. Schafer AI, Churchill WH, Ames P, Weinstein L: The influence of chemotherapy on response of patients with hematological malignancies to influenza vaccine. Cancer 1979, 43: 25–30.

    PubMed  Google Scholar 

  10. Steinherz PG, Brown AE, Gross PA, Braun D, Ghavimi F, Wollner N, Rosen G, Armstrong D, Miller DR: Influenza immunization of children with neoplastic diseases. Cancer 1980, 45: 750–756.

    PubMed  Google Scholar 

  11. Gross PA, Gould AL, Brown AE: Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies. Reviews of Infectious Diseases 1985, 7: 613–618.

    PubMed  Google Scholar 

  12. Gross PA: Reactogenicity and immunogenicity of bivalent influenza vaccine in one- and two-dose trials in children: a summary. Journal of Infectious Diseases 1977, 136, Supplement: 616–625.

    Google Scholar 

  13. Mancini G, Arangio-Ruiz G, Bianchi B, Diana L, Maccia T, Donatelli I, Castrucci MR, Campitelli L, Ruggieri A: Influenza vaccination in elderly residents in nursing homes: immune response to trivalent and monovalent inactivated influenza virus vaccine in the season 1986–87. European Journal of Epidemiology 1989, 5: 214–218.

    PubMed  Google Scholar 

  14. MacKenzie JS: Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly. British Medical Journal 1977, 1: 200–202.

    PubMed  Google Scholar 

  15. Palmer DF, Coleman MT, Dowdle WR, Schild GC: Advanced laboratory techniques for influenza diagnosis. Center for Disease Control, Atlanta, 1975.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lo, W., Whimbey, E., Elting, L. et al. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur. J. Clin. Microbiol. Infect. Dis. 12, 778–782 (1993). https://doi.org/10.1007/BF02098469

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02098469

Keywords

Navigation